In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from GMO testing service providers, makers of diagnostic technology, and OEMs of laboratory equipment were examples of supply-side sources. Quality assurance directors, laboratory managers, regulatory compliance officers, and procurement leads from food and beverage businesses, seed companies, agricultural biotechnology companies, third-party testing laboratories, and government inspection agencies were examples of demand-side suppliers. In addition to gathering information on testing protocol standards, pricing tactics, and certification dynamics, primary research verified technology adoption timescales and validated market segmentation.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (38%), Europe (29%), Asia-Pacific (25%), Rest of World (8%)
Global market valuation was derived through revenue mapping and testing volume analysis. The methodology included:
Identification of 40+ key testing service providers and technology manufacturers across North America, Europe, Asia-Pacific, and Latin America
Technology mapping across polymerase chain reaction (PCR), next-generation sequencing (NGS), microarrays, ELISA, and phenotypic screening methods
Analysis of reported and modeled annual revenues specific to GMO testing portfolios
Coverage of service providers and manufacturers representing 70-75% of global market share in 2024
Extrapolation using bottom-up (testing volume × ASP by country and application) and top-down (service provider revenue validation) approaches to derive segment-specific valuations for food testing, seeds testing, animal feed testing, and environmental testing applications